Blimet Pharma Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 27-05-2024
- Paid Up Capital ₹ 0.10 M
as on 27-05-2024
- Company Age 6 Year, 11 Days
- Last Filing with ROC 31 Mar 2021
- Revenue 251611.07%
(FY 2020)
- Profit 42406.47%
(FY 2020)
- Ebitda -209491.18%
(FY 2020)
- Net Worth 42.41%
(FY 2020)
- Total Assets 243.91%
(FY 2020)
About Blimet Pharma
The Company is engaged in the Business Services Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2021. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Nitin Pawar, Akshay Kadam, and Saraswati Khedkar serve as directors at the Company.
- CIN/LLPIN
U74999MH2018PTC316708
- Company No.
316708
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
01 Nov 2018
- Date of AGM
30 Nov 2021
- Date of Balance Sheet
31 Mar 2021
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Aurangabad, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Blimet Pharma?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Nitin Pawar  | Director | 01-Nov-2018 | Current |
| Akshay Kadam | Director | 01-Nov-2018 | Current |
| Saraswati Khedkar | Director | 01-Nov-2018 | Current |
Financial Performance and Corporate Structure Insights of Blimet Pharma.
Blimet Pharma Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 251611.07% increase. The company also saw a substantial improvement in profitability, with a 42406.47% increase in profit. The company's net worth Soared by an impressive increase of 42.41%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Blimet Pharma?
Unlock access to Blimet Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Blimet Pharma?
Unlock and access historical data on people associated with Blimet Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Blimet Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Blimet Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
